EPA’s James “Jim” Jones was named Wednesday as the first FDA Deputy Commissioner for Human Foods.
In an expanded position, he will fill the voids left at the FDA by the February departure of Frank
Continue Reading FDA Commissioner names EPA insider to agency’s top food safety post
— OPINION —
Dear Editor,
As an advocate for comprehensive organizational change in FDA’s Food Program, I give Commissioner Califf and his team the credit they are due for the changes he announced this week.
Continue Reading Letter to the Editor: Credit where credit is due
The head of the Food and Drug Administration says his evolving plan to restructure the food side of the agency is moving forward with changes planned for regulatory affairs, but two key observers say the
Continue Reading Some question the FDA commissioner’s plan for the reorganization of the agency’s regulatory office
An appropriations bill from a committee in the U.S. House of Representatives would direct the FDA to unify its food program under one person.
The move echoes the sentiment from a House committee, former FDA
Continue Reading House committee directs FDA Commissioner to unify FDA food programs with a clear chain of command
Eleven organizations that work closely with the Food and Drug Administration are asking bipartisan congressional leaders to work with them on “several pressing food safety issues this year.”
The eleven who’ve written congressional leaders include:
Continue Reading Food safety groups pitch congressional leaders on the inside game
Several weeks ago, food safety advocate Bill Marler launched his campaign to “Get the ‘F’ out of the FDA.”
Marler proposed that Congress split the Food and Drug Administration into two separate
Continue Reading It is time to rebuild the U.S. food safety system
— OPINION —
Editor’s note: This is the March 28 written statement of Frank Yiannas, M.P.H.Prior FDA Deputy Commissioner, Food Policy & Response (Nov 2018 – Feb 2023) for the Subcommitte On Health Care And
Continue Reading Testimony from former FDA deputy commissioner on infant formula crisis
— OPINION —
Editor’s note: Following is Tuesday’s testimony of Peter Lurie, MD, MPH, President and Executive Director, CSPI, before the U.S. House of Representatives Committee on Oversight and Accountability Subcommittee on Health Care and
Continue Reading Testimony from the head of the Center for Science in the Public Interest on the infant formula crisis
A congressional subcommittee hearing Tuesday on the infant formula crisis of 2022 not only explored how the crisis occurred but also examined how the structure of the FDA hampered efforts to resolve the situation and
Continue Reading Witnesses tell congressional subcommittee that infant formula crisis was example of FDA problems
Three of FDA’s former food safety chiefs have come together today to submit comments to a U.S. House of Representative’s oversight committee focused on chain of command problems at the agency.
The former Food and
Continue Reading Former FDA officials tell congressional committee that agency needs uninterrupted chain of command